SGK1 and osteoporosis: Consequently, the inhibition of the aberrant activation of SGK1 and the mitigation of the effects of inflammatory cytokines on bone metabolic homeostasis may emerge as a novel therapeutic approach for the treatment of senile osteoporosis in the future.